Leading generics pharmaceutical company
The Trusted Manufacturer of Hydroxycarbamide (THAROLAX) Tablets in India Taj Pharmaceuticals Ltd, a globally recognized name in the pharmaceutical industry, stands as one of the leading manufacturers, suppliers, and exporters of Hydroxycarbamide (Hydroxyurea) Tablets in India. Manufactured under the brand name THAROLAX, these tablets are produced at Taj Pharma’s state-of-the-art facility in Vapi, Gujarat, ensuring […]
Leading Manufacturer, Exporter and Supplier of Hydroxycarbamide (THAROLAX) Tablets 500mg in India Taj Pharmaceuticals Ltd, headquartered in Vapi, Gujarat, India, stands as a globally recognized and trusted name in the manufacturing, exporting, and supplying of Hydroxycarbamide (Hydroxyurea) Tablets. Known under the brand name THAROLAX, these tablets are a critical medication used in the treatment of […]
Leading Pregabalin Capsules Manufacturer, Exporter and Supplier in India Setting Global Standards in Pregabalin Capsule Manufacturing Taj Pharmaceuticals Ltd, a reputed pharmaceutical manufacturer from Vapi, Gujarat, India, is recognized globally for its excellence in producing Pregabalin Capsules of the highest quality and purity. As a WHO-GMP and ISO-certified manufacturer, we adhere to stringent international standards […]
Cases of thyroid cancer are on the rise in the United States, and experts want you to know how people at high risk for the disease can detect it early. According to the American Cancer Society, 54,000 new cases will be diagnosed in the United States in 2018. And three out of four of these […]
I’ve lived with bouts of deep depression my whole life. I’m not afraid or ashamed to say it. It’s just the way that it is and what makes me, me. It’s a part of who I am. I don’t think of it as mental illness or a disorder or a disease. It’s just part of […]
The FDA has issued a statement to promote the development of complex generic drugs to ensure access for patients and healthy drug competition The FDA has released a statement highlighting practices to improve the development of complex generic drugs in order to promote drug competition and patient access. The FDA Commissioner Scott Gottlieb wrote: […]
